The Glacial RxTM Difference
World-recognized scientific founders uncovered and harnessed a previously unknown biological relationship that promises to reshape the way we treat skin conditions.
The science behind the Glacial Rx™ treatment is like nothing else on the market. Cryomodulation™ truly is the next revolution in CryoAesthetics™.
R2 harnessed this discovery and since 2014 has conducted research and human trials that have resulted in the novel Glacial RxTM system.
Melanin Supression Process
- Freeze delivered down to melanocytes
- Ice nucleation impairs transfer of melanin into keratinocytes
- Epidermal cells turn over with less melanin deposition
- Cold stress accelerates exfoliation
Remove benign lesions by impairing ability of melanocytes to deliver melanin, accelerating exfoliation and normalizing pigment deposition.
Reduce redness and edema plus enhance evenness by suppressing chronic and procedure-related inflammation.
Support delivery of refreshing sensory experience using cooling’s natural analgesic effect.
Globally recognized scientific founders
The team at Blossom Innovations, LLC, and Massachusetts General Hospital seized upon the idea that melanin could be suppressed with cold. They immediately understood that if results could be delivered consistently, cold offered a series of benefits patients and providers would love.
R. ROX ANDERSON, M.D.
DIETER MANSTEIN, M.D., PH.D.
HENRY H. L. CHAN, M.D., PH.D.
“Human skin pigmentation is like an ecosystem - a balance among many living cells, interacting and responding to our environment. R2 has shown that softly freezing skin can lighten it and treat some kinds of pigmented lesions.”- R. Rox Anderson, M.D.
Never satisfied with good enough, the R2 Technologies team spent years taking an idea
and converting it into a reproducible treatment patients love.
5 contact cooling
over 600 subjects treated.
More added daily
melanin suppression and
intact skin architecture
Schedule an introduction
Learn how Glacial RxTM will help your practice
• Attract new patients
• Delegable treatment
• Payback in under 5 months